IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 171 filers reported holding IVERIC BIO INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $26,751,043 | +216.0% | 679,996 | +95.4% | 0.01% | +150.0% |
| Q1 2023 | $8,466,159 | -47.8% | 347,972 | -54.0% | 0.00% | -50.0% |
| Q4 2022 | $16,210,989 | -77.4% | 757,169 | -81.0% | 0.00% | -75.0% |
| Q3 2022 | $71,673,000 | +1233.5% | 3,995,171 | +615.0% | 0.02% | +1500.0% |
| Q2 2022 | $5,375,000 | +77.3% | 558,744 | +210.3% | 0.00% | – |
| Q1 2022 | $3,031,000 | +167.3% | 180,073 | +165.5% | 0.00% | – |
| Q4 2021 | $1,134,000 | -91.8% | 67,826 | -92.0% | 0.00% | -100.0% |
| Q3 2021 | $13,794,000 | +388.1% | 849,380 | +89.7% | 0.00% | +100.0% |
| Q2 2021 | $2,826,000 | -61.7% | 447,844 | -62.5% | 0.00% | 0.0% |
| Q1 2021 | $7,381,000 | -63.1% | 1,194,335 | -58.7% | 0.00% | -80.0% |
| Q4 2020 | $20,003,000 | +147.8% | 2,894,719 | +102.3% | 0.01% | +150.0% |
| Q3 2020 | $8,073,000 | +1316.3% | 1,431,247 | +1179.2% | 0.00% | – |
| Q2 2020 | $570,000 | +470.0% | 111,883 | +283.2% | 0.00% | – |
| Q1 2020 | $100,000 | -85.6% | 29,200 | -63.9% | 0.00% | – |
| Q4 2019 | $694,000 | – | 80,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |